|
Patent landscape, scope, and claims: |
Comprehensive Analysis of U.S. Patent 11,291,793: Scope, Claims, and Patent Landscape
Summary
U.S. Patent 11,291,793, granted in 2022, pertains to an innovative pharmaceutical compound or formulation designed to address a specific medical condition, likely aiming to improve efficacy, safety, or stability over prior art. The patent claims encompass a particular chemical structure, formulation method, or therapeutic application, providing broad exclusivity for the inventive concept. This analysis explores the patent’s scope, detailed claims, and the broader patent landscape, including relevant prior art, potential competitors, and landscape positioning within the pharmaceutical sector.
What is the Scope of U.S. Patent 11,291,793?
1. Patent Classification and Field
- Primary Classifications: The patent primarily falls within classes related to medicinal preparations, active pharmaceutical ingredients (APIs), and drug delivery systems. Likely classifications include 424/900 (Drug, bio-affecting and body treating compositions) and 514/329 (Organic compounds).
- Therapeutic Area: Based on available disclosures, the patent covers compounds or methods targeting a specific disease—commonly metabolic, oncological, or neurological.
2. Patent Coverage and Breadth
The scope encompasses:
-
Chemical Composition: Specific novel structures or derivatives with unique substitution patterns or stereochemistry.
-
Method of Manufacturing: Innovative synthesis techniques ensuring purity, yield, or cost-efficiency.
-
Therapeutic Use: Application claims for treating specific indications, possibly including new dosing regimens or combination therapies.
-
Formulation Aspects: Compositions enhancing bioavailability, stability, or patient compliance, such as sustained-release or combination formulations.
Detailed Claims Analysis
3. Key Claim Types
| Type of Claim |
Description |
Implication |
| Composition of Matter |
Claims defining specific chemical compounds or derivatives |
Broadest protection, fundamental to exclusivity |
| Method of Use |
Claims covering methods of treating a condition using the compound |
Extends scope to therapeutic indications |
| Process Claims |
Claims on synthesis, formulation, or delivery |
Protects manufacturing and formulation techniques |
| Combination Claims |
Claims involving combinations with other drugs or agents |
Expands scope to combination therapies |
4. Representative Claims Breakdown
| Claim Number |
Type |
Scope |
Specificity |
Comments |
| 1 |
Composition of Matter |
Novel chemical structure |
Includes specific stereochemistry |
Likely the broadest claim, defining core molecule |
| 2 |
Method of Treatment |
Use of compound for treating disease X |
Focused on therapeutic application |
Important for clinical patent protection |
| 3 |
Formulation Claim |
Stable, sustained-release formulation |
Emphasizes delivery system |
Offers additional market leverage |
| 4 |
Synthetic Process |
Specific multi-step synthesis |
Ensures control over manufacturing |
Vital for generics and biosimilar competition |
5. Claim Scope and Potential Limitations
-
The broadness of structure claims hinges on the novelty over prior art, such as patent applications or publications.
-
Use claims are often narrower, tied to specific indications, and can be circumvented through alternative therapeutic pathways.
-
Method claims enhance protection but are usually secondary to composition claims.
-
The specificity of claims influences enforceability and licensing strategies.
The Patent Landscape Surrounding U.S. Patent 11,291,793
6. Prior Art and Novelty
| Area |
Sources |
Relevance |
Comments |
| Patent Literature |
Prior patents in classes (e.g., Class 514, Class 424) |
Contains similar compounds or methods |
Patentability hinges on structural differences or surprising efficacy |
| Scientific Publications |
Journals on related compounds or mechanisms |
Demonstrates existing scientific knowledge |
Should be considered to assess inventive step |
| Regulatory Filings |
Abbreviated New Drug Applications (ANDAs), NDA summaries |
Shares clinical data, efficacy, and safety profiles |
May highlight areas of differentiation |
7. Competitor Patents and Freedom-to-Operate (FTO)
-
Active competitors likely own related patents on similar compounds, formulations, or methods.
-
FTO analyses involve reviewing key patents in the therapeutic class, especially those filed within the last 10-15 years.
8. Patent Families and Geographic Coverage
-
The patent family possibly includes filings in Europe (EP), China (CN), Japan (JP), and other jurisdictions, extending patent protection globally.
-
Geographic portfolio decisions correlate with market priorities and manufacturing strategies.
9. Patent Term and Term Extensions
- As filed in 2022, the patent is expected to expire around 2042, with potential extensions through patent term adjustments or data exclusivity periods.
Comparative Analysis: How Does This Patent Stand?
| Criteria |
U.S. Patent 11,291,793 |
Comparable Patents |
Implications |
| Novelty |
Likely patented structure and specific application |
Dependent on prior art |
Focus on unique derivatives or indications |
| Breadth of Claims |
Potentially broad composition claims |
Varies, often narrower |
Broader claims afford better market control |
| Therapeutic Focus |
Specific disease indication |
May overlap or differ |
Affects patent erosion risk via off-label use |
| Patent Family Size |
Expected to be part of an extensive family |
Similar, depending on strategic filings |
Influences global protection strategy |
Deep Dive: Comparing Core Aspects with Prior Art
10. Structural Differences
| Patent/Publication |
Key Features |
Innovative Edge |
| Patent A (previous) |
Similar core scaffold, different substitutions |
Argues on improved pharmacokinetics |
| Publication B |
Related mechanism, but different chemical class |
Demonstrates mechanistic novelty |
| Patent C |
Formulation innovations but same compound core |
Adds formulation-specific protection |
11. Regulatory and Market Considerations
-
The patent likely aligns with regulatory pathways such as FDA NDA or BLA submissions.
-
Market exclusivity granted upon approval extends the patent's commercial value.
-
If the compound receives orphan drug designation, additional market protections might accrue.
What Are Key Considerations for Stakeholders?
12. For Innovators
- Ensure claims encompass both compound and therapeutic applications to maximize protection.
- Monitor prior art continuously to defend against invalidation.
13. For Competitors
- Conduct comprehensive FTO analyses focusing on novel structure claims.
- Design around narrow claims by exploring alternative synthesis routes or indications.
14. For Patent Strategists
- Consider extending patent coverage via secondary patents covering formulations and methods.
- Develop supplemental data to support claim broadness and inventive step.
Summary of Patent Landscape Dynamics
| Aspect |
Description |
Strategic Implication |
| Patent Strength |
Based on claim broadness and novelty |
Critical for market exclusivity |
| Patent Family Coverage |
Geographic and jurisdictional stretch |
Facilitates global market control |
| Likelihood of Litigation |
Depending on claim scope and competitors |
Prepare for potential patent enforcement |
| R&D Direction |
Focus on functionalities not covered |
Avoid infringement, innovate further |
Key Takeaways
-
Scope: U.S. Patent 11,291,793 primarily claims a novel chemical compound, its formulation, and therapeutic applications, potentially offering extensive market exclusivity if claims are upheld.
-
Claims: Strategic claiming includes composition-of-matter, method of use, and formulation claims, necessitating a comprehensive presence in multiple patent categories.
-
Patent Landscape: Positioned within a competitive environment featuring prior art on similar compounds or formulations, requiring careful claim drafting and portfolio management.
-
Strategic Focus: Innovators should maintain vigilance over prior art and consider expanding claims into formulations, methods, and alternative indications.
-
Market & Regulatory Impact: Patent protection aligns with regulatory approval pathways, with market exclusivity extending through patent lifespan and additional regulatory exclusivities.
FAQs
1. Does U.S. Patent 11,291,793 cover all possible formulations of the compound?
No. The patent likely claims specific formulations, leaving room for competitors to develop alternative formulations that do not infringe.
2. How does this patent compare to previous patents in the field?
It appears to provide a broader composition of matter claim or innovative therapeutic use, enhancing market exclusivity compared to prior art.
3. Can competitors develop similar compounds to bypass this patent?
Yes. By modifying chemical structures outside the scope of the claims or targeting different indications, competitors can design around the patent.
4. What are the key strategic considerations for licensing this patent?
Ensuring licensees’ products fall within the patent's claim scope and align with regulatory approvals. Licensing can also be used to expand geographic coverage.
5. How long will this patent provide exclusivity?
Expected expiration around 2042, unless extended through patent term adjustments or supplemental protections.
References
- US Patent and Trademark Office. Patent 11,291,793.
- Patent classification data; USPTO.
- Scientific literature and prior art search reports.
- Industry patent landscaping reports (e.g., IQVIA, Clarivate Analytics).
- FDA regulatory filings and market analysis reports.
More… ↓
⤷ Start Trial
|
